Evidence map›Paper›PMID 38407690›Full record

ArticleMolecular biotechnology2025

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway.

Si-Yu Chen, Xin Chen, Sai Zhu, Jin-Jin Xu, Xiao-Feng Li, Na-Na Yin, Yan-Yan Xiao, Cheng Huang, Jun Li

Open access · hybridAbstract read
In one paragraph

Article in Molecular biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Si-Yu ChenDepartment of Pharmacy, Hefei BOE Hospital, Intersection of Dongfang Avenue and Wenzhong Road, Hefei, China.ORCID http://orcid.org/0000-0002-5173-3349
Xin ChenSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Sai ZhuSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Jin-Jin XuSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Xiao-Feng LiSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Na-Na YinSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Yan-Yan XiaoSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Cheng HuangSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China.
Jun LiSchool of Pharmacy, Anhui Medical University, 81 Mei Shan Road, Hefei, 230032, Anhui, China. lj@ahmu.edu.cn.
Anhui Medical University · CNHefei First People's Hospital · CN

Funding

the National Science Foundation of China No. 81970534
6 · The paper itself

Abstract

In hepatic fibrosis (HF), hepatic stellate cells (HSCs) form the extracellular matrix (ECM), and the pathological accumulation of ECM in the liver leads to inflammation. Our previous research found that miR-324-3p was down-regulated in culture-activated human HSCs. However, the precise effect of miR-324-3p on HF has not been elucidated. In this study, the HF mouse models were induced through directly injecting carbon tetrachloride (CCl

Indexed as

Carbon TetrachlorideHepatic Stellate CellsLiver CirrhosisMicroRNAsSignal TransductionSmad4 ProteinActinsAnimalsApoptosisCell LineCell ProliferationDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLActinsCarbon TetrachlorideMicroRNAsSmad4 ProteinSmad4 protein, mouseTransforming Growth Factor beta1Hepatic fibrosisLX-2 cell activationmiR-324-3pSMAD4

Identifiers

PMID38407690
PMCPMC11711260
OpenAlexW4392162633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.